Search Results - "Tripolt, Norbert"

Refine Results
  1. 1
  2. 2
  3. 3

    Effect of Lactobacillus casei Shirota supplementation on trimethylamine- N -oxide levels in patients with metabolic syndrome: An open-label, randomized study by Tripolt, Norbert J, Leber, Bettina, Triebl, Alexander, Köfeler, Harald, Stadlbauer, Vanessa, Sourij, Harald

    Published in Atherosclerosis (01-09-2015)
    “…Abstract Background Recent studies in animal models have shown a link between ingestion of dietary phosphatidylcholine (PC), choline, l -carnitine and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial by Aziz, Faisal, Tripolt, Norbert J, Pferschy, Peter N, Kolesnik, Ewald, Mangge, Harald, Curcic, Pero, Hermann, Markus, Meinitzer, Andreas, von Lewinski, Dirk, Sourij, Harald

    Published in Cardiovascular diabetology (20-07-2023)
    “…The relationship between sodium glucose co-transporter 2 inhibitors (SGLT2i) and trimethylamine N-oxide (TMAO) following acute myocardial infarction (AMI) is…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial by Aziz, Faisal, Tripolt, Norbert J, Pferschy, Peter N, Scharnagl, Hubert, Abdellatif, Mahmoud, Oulhaj, Abderrahim, Benedikt, Martin, Kolesnik, Ewald, von Lewinski, Dirk, Sourij, Harald

    Published in Cardiovascular diabetology (27-04-2024)
    “…Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have been suggested to exert cardioprotective effects in patients with heart failure, possibly by improving…”
    Get full text
    Journal Article
  12. 12

    Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial by Pammer, Anja, Obermayer, Anna, Stadler, Julia T, Pferschy, Peter N, Tripolt, Norbert J, Habisch, Hansjörg, Madl, Tobias, Sourij, Harald, Marsche, Gunther

    Published in Cardiovascular diabetology (12-09-2024)
    “…Cardiovascular disease represents a significant risk factor for mortality in individuals with type 2 diabetes mellitus (T2DM). High-density lipoprotein (HDL)…”
    Get full text
    Journal Article
  13. 13

    Timing of SGLT2i initiation after acute myocardial infarction by von Lewinski, Dirk, Kolesnik, Ewald, Aziz, Faisal, Benedikt, Martin, Tripolt, Norbert J., Wallner, Markus, Pferschy, Peter N., von Lewinski, Friederike, Schwegel, Nora, Holman, Rury R., Oulhaj, Abderrahim, Moertl, Deddo, Siller-Matula, Jolanta, Sourij, Harald

    Published in Cardiovascular diabetology (30-09-2023)
    “…Abstract Background Pharmacological post-MI treatment is routinely initiated at intensive/cardiac care units. However, solid evidence for an early start of…”
    Get full text
    Journal Article
  14. 14

    INTERmittent FASTing in people with insulin‐treated type 2 diabetes mellitus – the INTERFAST‐2 study protocol by Obermayer, Anna, Tripolt, Norbert J., Pferschy, Peter N., Kojzar, Harald, Jacan, Angela, Schauer, Markus, Aziz, Faisal, Oulhaj, Abderrahim, Aberer, Felix, Sourij, Caren, Obermayer‐Pietsch, Barbara, Stadlbauer, Vanessa, Sourij, Harald

    Published in Diabetic medicine (01-06-2022)
    “…Aim Intermittent fasting, a dietary intervention of alternate eating and fasting, has gained popularity in people trying to lose weight. Intermittent fasting…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20